Ethereum traded near $1,900 on Binance’s 3 day ETHUSDT chart after a fresh pullback left price sitting just above a rising support band that has guided the trendEthereum traded near $1,900 on Binance’s 3 day ETHUSDT chart after a fresh pullback left price sitting just above a rising support band that has guided the trend

Ethereum Price Prediction: $1,390 or $880 Ahead?

2026/02/25 18:46
3 min read

Ethereum traded near $1,900 on Binance’s 3 day ETHUSDT chart after a fresh pullback left price sitting just above a rising support band that has guided the trend since mid 2022. The latest candle in the screenshot showed ETH down about 1.5%, with price ranging from roughly $1,812 to $1,870 before closing near the lower end of that move.

ETH tests rising support as Don flags two paths back to an uptrend

Chart analyst Don, who posts as DonWedge on X, said Ethereum has “two scenarios” from here. First, a bounce off the current support zone. Second, a deeper dip that briefly “sweeps” the lower major support area before buyers regain control. He added that both routes still point back toward an uptrend, which he said makes timing the bottom difficult.

Ethereum Price Prediction: $1,390 or $880 Ahead?

Ethereum USDT 3 Day Chart. Source: DonWedge on X

On the chart, two upward sloping magenta lines mark a support corridor, while a higher yellow line labels “major resistance” near the upper range that capped prior rallies. A mid range yellow level sits around the low $2,000s and is tagged as resistance on the chart, suggesting it remains a nearby reclaim point if price rebounds from the current base.

Don’s projected paths appear as dashed white lines. One path shows a quick pivot higher from the support band, while the other sketches a final dip into the lower support before a stronger climb. His post also framed Ethereum’s current stretch as quiet and easy to ignore, while warning that fast moves often start after traders stop paying attention.

ETH risks deeper drop if 0.25 range fails, as post points to Vitalik selling

Also, Ethereum is testing the lower end of a long-running range on the multi year ETHUSD chart, as analyst Greeny warned that a breakdown could open room for a deeper move lower. In a post on X, Greeny said ETH has “three figure” risk if it cannot hold the 0.25 range level. Greeny also tied that risk to what he called continued “click sell” behavior by Vitalik Buterin, without providing onchain proof in the post.

Ethereum Multi Year Chart. Source: Greeny on X

The chart shows repeated rejections near the upper resistance band, followed by declines toward long term support. Red dashed levels mark former reaction zones where price paused before changing direction. Each visit to the lower range has drawn buying interest in the past. However, earlier breaks from similar areas also led to extended declines before new bases formed.

Greeny listed two downside reference levels if the 0.25 range level fails. He pointed to $1,390 as the first target and $880 as the next lower area on the chart. Those zones line up with prior consolidation regions where price previously stabilized before broader recoveries.

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0006471
$0.0006471$0.0006471
-3.20%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion
Share
AI Journal2026/02/25 21:36
How BlackRock and JPMorgan Are Quietly Building On Blockchain - Institutional DeFi Is Here

How BlackRock and JPMorgan Are Quietly Building On Blockchain - Institutional DeFi Is Here

read more
Share
Coinstats2025/09/18 19:43